Literature DB >> 30262418

Trastuzumab, not lapatinib, has therapeutic effects on Chinese patients with HER2-positive cholangiocarcinoma.

Hai-Bo Mou1, Wen-Dong Li2, Yan-Jun Shen2, Jun-Ping Shi3, Xiao-Di Guo2, Ming Yao3, Kai Wang4, Ting Zhang5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30262418     DOI： 10.1016/j.hbpd.2018.09.011

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


× No keyword cloud information.
  2 in total

1.  Effectiveness of Olaparib Treatment in a Patient with Gallbladder Cancer with an ATM-Inactivating Mutation.

Authors:  Wei Zhang; Junping Shi; Rentao Li; Zhiqiang Han; Ling Li; Guanghao Li; Bo Yang; Qiang Yin; Yingying Wang; Yan Ke; Qiang Li
Journal:  Oncologist       Date:  2020-02-11

2.  Effectiveness of Trastuzumab Combined With Capecitabine Treatment in a Patient With Hilar Cholangiocarcinoma Complicated by Liver Metastases With an ERBB2-Activating Mutation: A Case Report.

Authors:  Daobing Zeng; Xiaofei Zhao; Liang Di; Luyan Lou; Yanfang Song; Yanrui Zhang; Huanhuan Liu; Guangming Li
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.